Stocks
Sabra Health Care (SBRA) EBITDA margin US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 51.8% | 34.7% | 48.2% | 58.7% | 59.0% | 53.9% | ||
| Changes by years, y/y, % | +17pp | -17pp | +13pp | +11pp | +0pp | -3.3% | |||
Sabra Health Care. EBITDA margin, %
Sabra Health Care. EBITDA margin, changes, pp
Sabra Health Care (SBRA) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 60.6% | 72.5% | 52.8% | 51.0% | 41.8% | 53.9% | |
| Changes by years, y/y, % | +2pp | +18pp | -4pp | -18pp | -19pp | |||
| Changes by quarters, q/q, % | -8pp | +12pp | -20pp | -2pp | -9pp | |||
